C. Moore

发表

Dopamine Modulates Release from Corticostriatal Terminals

R. Palmiter, S. Robinson, C. Meshul, 2004, The Journal of Neuroscience.

Correlates and Analysis of Motor Function in Humans and Animal Models of Parkinson’s Disease

B. Fisher, G. Petzinger, C. Meshul, 2011 .

Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism

C. Meshul, C. Moore, A. M. Ribeiro, 2019, Brain Research Bulletin.

Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway

C. Meshul, C. Moore, A. Massie, 2021, Frontiers in Cellular Neuroscience.

Effects of Subthalamic Nucleus Lesions and Stimulation upon Corticostriatal Afferents in the 6-Hydroxydopamine-Lesioned Rat

R. J. Koch, C. Meshul, C. Moore, 2012, PloS one.

NG2 glia-derived GABA release tunes inhibitory synapses and contributes to stress-induced anxiety

S. Duan, Tian-Le Xu, C. Meshul, 2021, Nature Communications.

Dietary restriction affects striatal glutamate in the MPTP‐induced mouse model of nigrostriatal degeneration

Haley K Holmer, C. Meshul, C. Moore, 2005, Synapse.

Exercise in an animal model of Parkinson’s disease: Motor recovery but not restoration of the nigrostriatal pathway

C. Meshul, C. Moore, L. Pflibsen, 2017, Neuroscience.

Glutamate-Glutamine Transfer and Chronic Stress-Induced Sex Differences in Cocaine Responses

C. Meshul, C. Moore, Tonie S. Farris, 2018, Neuroscience.

Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs

T. Sherer, M. Frasier, C. Meshul, 2013, PloS one.

Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease

S. Totterdell, G. Meredith, C. Meshul, 2004, Experimental Neurology.

Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease

Carlos Cepeda, Michael S. Levine, C. Cepeda, 2017, Neurobiology of Disease.

Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism

Carolyn E. Jones, C. Meshul, C. Moore, 2019, Journal of neuroscience research.

Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson’s disease

C. Meshul, C. Moore, M. Sconce, 2015, Neuroscience.

Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration

O. Andreassen, C. Meshul, C. Moore, 2001, Psychopharmacology.

Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson’s disease

C. Meshul, C. Moore, Mo Xu, 2020, The European journal of neuroscience.

Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice

M. Chesselet, C. Cepeda, M. Levine, 2017, Stem cell reports.

Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter

L. Arckens, C. Meshul, Erica A. K. DePasquale, 2020, Molecular Psychiatry.

Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice

Jonathan E. Elliott, C. Meshul, C. Moore, 2018, Sleep.

Presynaptic Alpha-Synuclein Aggregation in a Mouse Model of Parkinson's Disease

C. Meshul, C. Moore, K. Spinelli, 2014, The Journal of Neuroscience.

Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine

C. Meshul, C. Moore, H. Holmer, 2005, Experimental Neurology.

Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function

S. Robinson, C. Meshul, C. Moore, 2003, Experimental Neurology.

Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease

C. Meshul, C. Moore, E. Kasanga, 2019, Neuroscience.

Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA

C. Meshul, C. Moore, Randa S. Eshaq, 2015, Front. Cell. Neurosci..

Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6‐hydroxydopamine‐lesioned rats

R. J. Koch, C. Meshul, C. Moore, 2010, Journal of neuroscience research.

Nicotine Alters Striatal Glutamate Function and Decreases the Apomorphine-Induced Contralateral Rotations in 6-OHDA-Lesioned Rats

C. Meshul, C. Moore, D. Kamel, 2002, Experimental Neurology.

Neurogenesis is Enhanced in Young Rats with Genetic Absence Epilepsy: An Immuno-electron Microscopic Study.

C. Meshul, C. Moore, O. T. Cilingir-Kaya, 2020, Turkish neurosurgery.

Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease

William A. Liguore, C. Meshul, C. Moore, 2020, Neuroscience.

Human Neural Stem Cells Differentiate and Integrate, Innervating Implanted zQ175 Huntington’s Disease Mouse Striatum

C. Cepeda, M. Levine, L. Thompson, 2021, bioRxiv.

Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice

William A. Liguore, C. Meshul, C. Moore, 2016, Brain Research.

Lesion of subthalamic or motor thalamic nucleus in 6‐hydroxydopamine‐treated rats: Effects on striatal glutamate and apomorphine‐induced contralateral rotations

C. Meshul, C. Moore, J. Frederickson, 2004, Synapse.

Early life sleep disruption alters glutamate and dendritic spines in prefrontal cortex and impairs cognitive flexibility in prairie voles

Carolyn E. Jones, C. Meshul, C. Moore, 2021, Current research in neurobiology.

l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

C. Meshul, C. Moore, H. Holmer, 2005, Neuroscience.

Alterations in Rat Striatal Glutamate Synapses Following a Lesion of the Cortico- and/or Nigrostriatal Pathway

C. Meshul, C. Moore, T. McNeill, 2000, Experimental Neurology.

Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum

R. J. Koch, C. Meshul, C. Moore, 2009, Neuroreport.

Subthalamic nucleus stimulation and lesioning have distinct state‐dependent effects upon striatal dopamine metabolism

R. J. Koch, C. Meshul, C. Moore, 2008, Synapse.

Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinson's disease

C. Meshul, A. Soumyanath, C. Moore, 2023, Molecular and Cellular Neuroscience.

High and low responders to novelty show differential effects in striatal glutamate

Haley K Holmer, G. Petzinger, C. Meshul, 2005, Synapse.

Blockade of NMDA receptors by MK‐801 reverses the changes in striatal glutamate immunolabeling in 6‐OHDA‐lesioned rats

S. Robinson, C. Meshul, C. Moore, 2001, Synapse.